Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.5710
-0.0390 (-6.39%)
Mar 31, 2025, 9:47 AM EDT - Market open
HBIO's stock price has decreased by -85.48% in the past year and price targets may not have had time to catch up.
Harvard Bioscience Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$4.50
Upside
+688.09%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Benchmark | Benchmark | Buy Maintains $5.5 → $4.5 | Buy | Maintains | $5.5 → $4.5 | +688.09% | Mar 24, 2025 |
Benchmark | Benchmark | Buy Reiterates $7 | Buy | Reiterates | $7 | +1,125.92% | Jun 22, 2023 |
Benchmark | Benchmark | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +1,125.92% | Apr 26, 2023 |
Keybanc | Keybanc | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +1,125.92% | Apr 26, 2023 |
Benchmark | Benchmark | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +600.53% | Mar 10, 2023 |
Keybanc | Keybanc | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +775.66% | Nov 9, 2022 |
Keybanc | Keybanc | Buy Maintains $10 → $7 | Buy | Maintains | $10 → $7 | +1,125.92% | Aug 5, 2022 |
Keybanc | Keybanc | Buy Initiates $6 | Buy | Initiates | $6 | +950.79% | Nov 10, 2020 |
Benchmark | Benchmark | Buy Maintains $3.5 → $4 | Buy | Maintains | $3.5 → $4 | +600.53% | Feb 27, 2020 |
Benchmark | Benchmark | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +1,301.05% | Jul 28, 2015 |